April 24, 2018
During a recent visit with one of my Parkinson’s patients, we decided he was a good candidate for deep brain stimulation. The treatment can help relieve severe tremors, stiffness and slowness, hallmarks of the disease. But when my patient’s health insurer got involved, what should have been a straightforward treatment got unnecessarily complicated.
April 19, 2018
“I thought maybe I wasn’t very good athletically.” That was iconic Olympic gold medalist Jackie Joyner-Kersee’s recollection of her first experience with asthma attacks.
April 17, 2018
After spending time and money to see a dermatologist, many patients with acne fail to fill their prescription. Cost sharing is the culprit, according to a recently published study.
April 13, 2018
Nearly 4 million babies are born each year in the United States. Yet physicians can have remarkably limited data about treating mothers’ health conditions during pregnancy.
April 10, 2018
Could a recent memorandum from the U.S. Patent and Trademark Office impact treatment options for patients? Washington, DC’s nonprofit Bipartisan Policy Center says: Yes.
April 6, 2018
What stands between patients and the treatment prescribed by their doctors? In some cases, the barriers are obvious. High co-pays…
April 5, 2018
What is innovative medicine worth to patients? It depends on which patient you ask. The disease a patient suffers from, its symptoms and their impact on a patient’s day-to-day life make the question a highly personal one. So does the extent to which a medicine addresses symptoms or even cures a disease.
March 29, 2018
Patients overpay for their prescriptions 23 percent of the time, a recently released study from the University of Southern California found. What’s worse – some pharmacists can’t tell patients when they’re paying too much.
March 27, 2018
How accessible is your health care? It all depends upon where you live, as a new report from the European Federation of Crohn's & Ulcerative Colitis Associations confirms.
March 26, 2018
Open dialogue is an important part of the drug approval process.
